https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/rss/The latest TBR Nederland Latest updates on MedicinesTYPO3enhttps://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/reimbursement-scheme-paxneury-r-guanfacine-263/https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/reimbursement-scheme-paxneury-r-guanfacine-263/Thu, 18 Dec 2025 14:09:46 +0100https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/tbr-nederland-instructional-videos-now-available-261/https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/tbr-nederland-instructional-videos-now-available-261/Fri, 24 Oct 2025 10:46:39 +0200https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/termination-reimbursement-scheme-broxil-r-259/https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/termination-reimbursement-scheme-broxil-r-259/Thu, 25 Sep 2025 10:26:31 +0200https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/termination-reimbursement-scheme-forxiga-r-xigduo-r-diabetes-257/https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/termination-reimbursement-scheme-forxiga-r-xigduo-r-diabetes-257/Wed, 30 Jul 2025 09:36:15 +0200https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/termination-reimbursement-scheme-cresemba-r-40-mg-en-100mg-255/https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/termination-reimbursement-scheme-cresemba-r-40-mg-en-100mg-255/Wed, 23 Jul 2025 10:07:19 +0200https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/update-reimbursement-scheme-cresemba-r-253/https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/update-reimbursement-scheme-cresemba-r-253/Fri, 28 Feb 2025 09:29:34 +0100https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/update-reimbursement-scheme-metoject-r-249/https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/update-reimbursement-scheme-metoject-r-249/Fri, 15 Nov 2024 09:07:26 +0100https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/reimbursement-scheme-mounjaro-kwikpen-r-for-the-indication-diabetes-mellitus-type-2-247/https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/reimbursement-scheme-mounjaro-kwikpen-r-for-the-indication-diabetes-mellitus-type-2-247/Wed, 06 Nov 2024 16:11:40 +0100https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/reimbursement-scheme-veoza-r-245/https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/reimbursement-scheme-veoza-r-245/Wed, 01 May 2024 11:18:58 +0200https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/update-reimbursement-scheme-elvanse-r-241/https://www.terugbetaalregeling.nl/overview-medicines/latest-updates-on-medicines/update-reimbursement-scheme-elvanse-r-241/Sun, 17 Mar 2024 20:02:04 +0100